Kalaris Therapeutics Inc
NASDAQ:KLRSBiotechnology
Healthcare
$2.30 +3.52%
+$0.16 today
- Market cap
- $54.75M
- Beta
- 0.14
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$1.86
52W Low $2.14High $11.88
Volume 0.07M
Average 0.08M
Private 5-step workspace
Build a KLRS investment thesis
Turn Kalaris Therapeutics Inc research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.